FDA clears Abbott Libre Duo 10-day dual glucose ketone monitor
The FDA has cleared Abbott’s Libre Duo 10-day dual glucose ketone monitor, described as the first U.S. device to track ketones continuously.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.